Continuous Renal Replacement Therapy (CRRT) Market Analysis By Product (System, Consumables), By Modality (Slow Continuous Ultra-Filtration, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis), And Segment Forecasts, 2014 - 2025

Published: Sep, 2017 | Pages: 100 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global continuous renal replacement therapy (CRRT) market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. The magnitude of the global target diseases, such as kidney diseases, and diabetes, is immense, with millions of new cases registered every year. This in turn is anticipated to boost the usage of CRRT treatment procedure.

Increasing incidence of volume overload, uremia, and hyperkalemia is increasing the application of renal replacement therapy, thereby boosting the overall growth of the market. For individuals suffering from acute kidney injury and severe multi-organ dysfunction, CRRT can prove to be beneficial when started early to maintain metabolic and volume homeostasis. In addition, CRRT prevents further worsening and development of symptoms and signs of renal failure.

Further key findings from the study suggest:

• The market study suggests that consumables segment dominated the overall market in 2016. The factors triggering the growth the segment are increasing application of hemofilters, fluids, charcoal filters and others consumables in CRRT

• Moreover, constant repeat purchase of consumables due to their one-time use is adding up to the revenue generation for the segment

• Amongst the modality segments, continuous venovenous hemofiltration (CVVH) occupied the largest share in 2016. Increasing incidence of fluid overload cases which is frequently found in acute kidney injury patients in critical care units, would boost growth of CVVH market.

• The continuous venovenous hemodiafiltration (CVVHDF) segment is expected to grow at the highest growth rate during the forecast period. CVVHDF is associated with improved survival rate when compared to other CRRT modalities due to combination of principles of diffusion and convection, i.e., hemofiltration and hemodialysis using a highly efficient hemodiafilter to remove both solute and fluid.

• North America accounted for the largest share in 2016, due to increasing prevalence of kidney disorders, and congestive heart failure in the region.

• In addition, increasing incidences of acute kidney injury cases leading to increased creatinine level, hyperkalemia, and uremia are a few high impact-rendering drivers for the market in North America.

• Asia Pacific is expected to foresee significant growth during the forecast period. The high-unmet medical needs pertaining to the target disease segment, such as diabetes, hypertension, and chronic kidney disease, coupled with constantly improving healthcare expenditure in the region are some of the key factors attributing to market growth

• Some of the major companies operating in this market are B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, NIPRO Corporation, Toray Medical Co., Ltd, NxStage Medical, Inc., Medtronic plc, and others.

 Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                 1.2 Data Analysis
                 1.3 Approaches for Market Estimation
                     1.3.1 Approach 1: Demand analysis &bottom-up approach
                     1.3.2 Approach 2: Top-down market estimation
                     1.3.3 Approach 3: Commodity flow and bottom-up market estimation
                     1.3.4 Approach 4: KoL perspective-based market sizing

Chapter 2 Executive Summary
                 2.1 Market Snapshot 

Chapter 3 Continuous Renal Replacement Therapy Market Variables, Trends & Scope
                 3.1 Market Segmentation
                 3.2 Market Size and Growth Prospects
                     3.2.1 Market driver analysis
                     3.2.2 Market restraint analysis
                 3.3 Key Opportunities Prioritized
                 3.4 Industry Analysis Porter's
                 3.5 PESTEL Analysis

Chapter 4 Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis
                 4.1 Continuous Renal Replacement Therapy Market: Product Movement Analysis, 2016 & 2025
                 4.2 System 
                     4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
                 4.3 Consumables
                     4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Continuous Renal Replacement Therapy Market: Modality Estimates & Trend Analysis
                 5.1 Continuous Renal Replacement Therapy Market: Modality Analysis, 2016 & 2025
                 5.2 Slow continuous ultra filtration
                     5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
                 5.3 Continuous venovenous hemofiltration
                     5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
                 5.4 Continuous venovenous hemodialysis
                     5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
                 5.5 Continuous venovenous hemodiafiltration
                     5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis, by Product & Modality
                 6.1 Continuous Renal Replacement Therapy Market Share by Region, 2016 & 2025 
                 6.2 North America
                     6.2.1 U.S.
                         6.2.1.1 Market estimates and forecasts, by product 2014 - 2025
                         6.2.1.2 Market estimates and forecasts, by modality 2014 - 2025
                     6.2.2 Canada
                         6.2.2.1 Market estimates and forecasts, by product 2014 - 2025
                         6.2.2.2 Market estimates and forecasts, by modality 2014 - 2025
                 6.3 Europe
                     6.3.1 UK
                         6.3.1.1 Market estimates and forecasts, by product 2014 - 2025
                         6.3.1.2 Market estimates and forecasts, by modality 2014 - 2025
                     6.3.2 Germany
                         6.3.2.1 Market estimates and forecasts, by product 2014 - 2025
                         6.3.2.2 Market estimates and forecasts, by modality 2014 - 2025
                 6.4 Asia Pacific
                     6.4.1 China
                         6.4.1.1 Market estimates and forecasts, by product 2014 - 2025
                         6.4.1.2 Market estimates and forecasts, by modality 2014 - 2025
                     6.4.2 Japan
                         6.4.2.1 Market estimates and forecasts, by product 2014 - 2025
                         6.4.2.2 Market estimates and forecasts, by modality 2014 - 2025
                 6.5 Latin America
                     6.5.1 Brazil
                         6.5.1.1 Market estimates and forecasts, by product 2014 - 2025
                         6.5.1.2 Market estimates and forecasts, by modality 2014 - 2025
                     6.5.2 Mexico
                         6.5.2.1 Market estimates and forecasts, by product 2014 - 2025
                         6.5.2.2 Market estimates and forecasts, by modality 2014 - 2025
                 6.6 MEA
                     6.6.1 South Africa
                         6.6.1.1 Market estimates and forecasts, by product 2014 - 2025
                         6.6.1.2 Market estimates and forecasts, by modality 2014 - 2025

Chapter 7 Competitive Landscape
                 7.1 Strategy Framework
                 7.2 Company Profiles
                     7.2.1 B. Braun Melsungen AG
                         7.2.1.1 Company overview
                         7.2.1.2 Financial performance
                         7.2.1.3 Product benchmarking
                         7.2.1.4 Strategic initiatives
                     7.2.2 Baxter International, Inc.
                         7.2.2.1 Company overview
                         7.2.2.2 Financial performance
                         7.2.2.3 Product benchmarking
                         7.2.2.4 Strategic initiatives
                     7.2.3 Fresenius Medical Care AG & Co. KGaA
                         7.2.3.1 Company overview
                         7.2.3.2 Financial performance
                         7.2.3.3 Product benchmarking
                         7.2.3.4 Strategic initiatives
                     7.2.4 Asahi Kasei Corporation
                         7.2.4.1 Company overview
                         7.2.4.2 Financial performance
                         7.2.4.3 Product benchmarking
                         7.2.4.4 Strategic initiatives
                     7.2.5 NIPRO Corporation 
                         7.2.5.1 Company overview
                         7.2.5.2 Financial performance
                         7.2.5.3 Product benchmarking
                         7.2.5.4 Strategic initiatives
                     7.2.6 Toray Medical Co., Ltd. 
                         7.2.6.1 Company overview
                         7.2.6.2 Financial performance
                         7.2.6.3 Product benchmarking
                         7.2.6.4 Strategic initiatives
                     7.2.7 NxStage Medical, Inc.
                         7.2.7.1 Company overview
                         7.2.7.2 Financial performance
                         7.2.7.3 Product benchmarking
                         7.2.7.4 Strategic initiatives
                     7.2.8 Medtronic plc 
                         7.2.8.1 Company overview
                         7.2.8.2 Financial performance
                         7.2.8.3 Product benchmarking
                         7.2.8.4 Strategic initiatives

List of Tables

TABLE 1 Continuous renal replacement therapy market - industry snapshot
TABLE 2 Continuous renal replacement therapy market, by product, 2014 - 2025 (USD Million)
TABLE 3 Continuous renal replacement therapy market, by modality, 2014 - 2025 (USD Million)
TABLE 4 Continuous renal replacement therapy market, by region, 2014 - 2025 (USD Million)
TABLE 5 Continuous renal replacement therapy market: Key market driver analysis
TABLE 6 Continuous renal replacement therapy market: Key market restraint analysis
TABLE 7 North America market, by product 2014 - 2025 (USD Million)
TABLE 8 North America market, by modality 2014 - 2025 (USD Million)
TABLE 9 U.S. market, by product 2014 - 2025 (USD Million)
TABLE 10 U.S. market, by modality 2014 - 2025 (USD Million)
TABLE 11 Canada market, by product 2014 - 2025 (USD Million)
TABLE 12 Canada market, by modality2014 - 2025 (USD Million)
TABLE 13 Europe market, by product 2014 - 2025 (USD Million)
TABLE 14 Europe market, by modality2014 - 2025 (USD Million)
TABLE 15 UK market, by product 2014 - 2025 (USD Million)
TABLE 16 UK market, by modality 2014 - 2025 (USD Million)
TABLE 17 Germany market, by product 2014 - 2025 (USD Million)
TABLE 18 Germany market, by modality 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific market, by product 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific market, by modality 2014 - 2025 (USD Million)
TABLE 21 Japan market, by product 2014 - 2025 (USD Million)
TABLE 22 Japan market, by modality 2014 - 2025 (USD Million)
TABLE 23 China market, by product 2014 - 2025 (USD Million)
TABLE 24 China market, by modality 2014 - 2025 (USD Million)
TABLE 25 Latin America market, by product 2014 - 2025 (USD Million)
TABLE 26 Latin America market, by modality 2014 - 2025 (USD Million)
TABLE 27 Brazil market, by product 2014 - 2025 (USD Million)
TABLE 28 Brazil market, by modality 2014 - 2025 (USD Million)
TABLE 29 Mexico market, by product 2014 - 2025 (USD Million)
TABLE 30 Mexico market, by modality 2014 - 2025 (USD Million)
TABLE 31 MEA market, by product 2014 - 2025 (USD Million)
TABLE 32 MEA market, by modality 2014 - 2025 (USD Million)
TABLE 33 South Africa market, by product 2014 - 2025 (USD Million)
TABLE 34 South Africa market, by modality 2014 - 2025 (USD Million)